Medicare Enrolled
Gail Lowery, FNP
Nurse Practitioner - Family · Southern Pines, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Lowery from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Lowery?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Lowery
Gail Lowery is a nurse practitioner - family in Southern Pines, NC, with 9 years of NPI registration. Based on federal Medicare data, Lowery performed 3,626 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Lowery received a total of $5,825 from 41 pharmaceutical and/or device companies across 336 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Lowery is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 2% volume in NC
$5,825 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,626
Medicare services
Top 2% in NC for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,140 | $18 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
360 | $104 | $260 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
300 | $8 | $20 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
228 | $9 | $65 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
210 | $5 | $28 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
205 | $5 | $42 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
203 | $10 | $77 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
152 | $16 | $90 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
151 | $9 | $79 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
150 | $22 | $125 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
91 | $6 | $72 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
90 | $5 | $39 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $66 | $196 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
60 | $29 | $150 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
57 | $40 | $188 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
49 | $16 | $115 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
27 | $5 | $33 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
20 | $6 | $40 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
17 | $6 | $40 |
| New patient office visit, complex (60-74 min) | 16 | $141 | $342 |
| Kidney function blood test panel | 15 | $9 | $62 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
14 | $12 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,825
Total received (2021-2024)
Avg $1,456/year across 4 years
Top 4% in NC for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
336
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,760
2023
$2,004
2022
$580
2021
$1,482
Payments by company (2024)
Lilly USA, LLC
$459
Novo Nordisk Inc
$186
Abbott Laboratories
$142
SANOFI-AVENTIS U.S. LLC
$96
Bayer Healthcare Pharmaceuticals Inc.
$93
Insulet Corporation
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Amgen Inc.
$67
RECORDATI_RARE_DISEASES_INC.
$63
Corcept Therapeutics
$58
Radius Health, Inc.
$56
Kyowa Kirin, Inc.
$47
BETA BIONICS, INC.
$47
ABBVIE INC.
$36
CeQur Corporation
$32
Novartis Pharmaceuticals Corporation
$29
Rhythm Pharmaceuticals, Inc.
$23
IBSA Pharma Inc.
$22
Neurocrine Biosciences, Inc.
$21
Medtronic, Inc.
$17
Amneal Pharmaceuticals LLC
$17
Ascendis Pharma Inc
$17
Azurity Pharmaceuticals, Inc.
$16
Tandem Diabetes Care, Inc.
$16
Mannkind Corporation
$15
Inspire Medical Systems, Inc.
$15
Top 3 companies account for 44.7% of 2024 payments
All-time payments by company (2021-2024) ›
Lilly USA, LLC
$1,312
Novo Nordisk Inc
$628
SANOFI-AVENTIS U.S. LLC
$399
Boehringer Ingelheim Pharmaceuticals, Inc.
$356
Amgen Inc.
$273
Abbott Laboratories
$268
Insulet Corporation
$265
Bayer Healthcare Pharmaceuticals Inc.
$234
Radius Health, Inc.
$232
Corcept Therapeutics
$213
AstraZeneca Pharmaceuticals LP
$148
IBSA Pharma Inc.
$133
Rhythm Pharmaceuticals, Inc.
$119
Novartis Pharmaceuticals Corporation
$95
Merck Sharp & Dohme Corporation
$93
Medtronic, Inc.
$91
ABBVIE INC.
$84
CeQur Corporation
$84
RECORDATI_RARE_DISEASES_INC.
$83
Amneal Pharmaceuticals LLC
$75
Ascendis Pharma Inc
$54
Azurity Pharmaceuticals, Inc.
$54
Kyowa Kirin, Inc.
$47
BETA BIONICS, INC.
$47
Acella Pharmaceuticals, LLC
$43
ARBOR PHARMACEUTICALS, INC.
$43
Ultragenyx Pharmaceutical Inc.
$37
Averitas Pharma Inc.
$35
Tandem Diabetes Care, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$33
Clarus Therapeutics Inc.
$29
Actelion Pharmaceuticals US, Inc.
$28
Xeris Pharmaceuticals, Inc.
$26
Neurocrine Biosciences, Inc.
$21
GRT US Holding, Inc.
$19
NESTLE HEALTHCARE NUTRITION INC.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Mannkind Corporation
$15
Inspire Medical Systems, Inc.
$15
LifeScan, Inc.
$14
Nevro Corp.
$13
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · CREON · CeQur Simplicity · Crysvita · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · GVOKE PFS · HORIZANT · HUMULIN · Horizant · IMCIVREE · INSPIRE · Imcivree · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · MULTAQ · NP Thyroid 60 · OPSUMIT · Omnia · Omnipod · OneTouch Verio Reflect · Ozempic · QUTENZA · Qutenza · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · TOUJEO · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · Wegovy · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
290
County median income
$82,837
Nearest hospital to ZIP centroid (approximate)
FIRSTHEALTH MOORE REGIONAL HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Lowery is a mixed practice specialist, with above-average Medicare volume (top 2% in NC).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Lowery experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Lowery performed 1,140 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Lowery receive payments from pharmaceutical companies?
Yes. Lowery received a total of $5,825 from 41 companies across 336 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Lowery's costs compare to other family nurse practitioners in Southern Pines?
Lowery's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Lowery) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Southern Pines
Browse family nurse practitioners in Southern Pines ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in NC
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in NC
Which NC family nurse practitioners receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology